Global Oncology Molecular Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Driven by the downstream end-users, the market of Oncology Molecular Diagnostics witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Oncology Molecular Diagnostics market is offered. The research provides insights for the global Oncology Molecular Diagnostics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Oncology Molecular Diagnostics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Oncology Molecular Diagnostics Market Segmentations:

    By Players:

    • Exiqon

    • Angsana Molecular and Diagnostics

    • Beckman Coulter

    • EXACT Sciences

    • Cepheid

    • GeneNew

    • Autogenomics

    • Asuragen

    • Agendia

    • Becton.Dickinson and Company

    • BioMerieux

    • Epigenomics

    • Cangen Biotechnologies

    • QIAGEN

    • Eragen

    • Diagnocure

    • Roche Diagnostics

    • Abbott Diagnostics


    By Types:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Oncology Molecular Diagnostics Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Oncology Molecular Diagnostics Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Molecular Diagnostics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Oncology Molecular Diagnostics Market Share by Types

      • 1.3.2 Global Oncology Molecular Diagnostics Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.3 Global Oncology Molecular Diagnostics Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.4 Global Oncology Molecular Diagnostics Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Oncology Molecular Diagnostics Market Share by End-Users

      • 1.4.2 Global Oncology Molecular Diagnostics Market Size and Growth Rate of End-User 1 from 2014 to 2026

      • 1.4.3 Global Oncology Molecular Diagnostics Market Size and Growth Rate of End-User 2 from 2014 to 2026

      • 1.4.4 Global Oncology Molecular Diagnostics Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumOncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Oncology Molecular Diagnostics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Molecular Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3


    4 Segmentation of Oncology Molecular Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Molecular Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Molecular Diagnostics for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Oncology Molecular Diagnostics for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Oncology Molecular Diagnostics for End-Users 3


    5 Market Analysis by Major Regions

    • 5.1 Global Oncology Molecular Diagnostics Production Analysis by Major Regions

    • 5.2 Global Oncology Molecular Diagnostics Consumption Analysis by Major Regions

    • 5.3 Global Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis


    6 Product Commodity of Oncology Molecular Diagnostics Market in Major Countries

    • 6.1 Top 5 Export Countries in Oncology Molecular Diagnostics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncology Molecular Diagnostics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Oncology Molecular Diagnostics Landscape Analysis

    • 7.1 North America Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 7.2 North America Oncology Molecular Diagnostics Landscape Analysis by Major End-Users

    • 7.3 North America Oncology Molecular Diagnostics Landscape Analysis by Major Countries

      • 7.3.1 United States Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 7.3.2 Canada Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 7.3.3 Mexico Oncology Molecular Diagnostics Market Volume and Growth Rate


    8 Europe Oncology Molecular Diagnostics Landscape Analysis

    • 8.1 Europe Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 8.2 Europe Oncology Molecular Diagnostics Landscape Analysis by Major End-Users

    • 8.3 Europe Oncology Molecular Diagnostics Landscape Analysis by Major Countries

      • 8.3.1 Germany Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.2 UK Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.3 France Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.4 Italy Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.6 Spain Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.7 Belgium Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.8 Poland Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.9 Russia Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 8.3.10 Turkey Oncology Molecular Diagnostics Market Volume and Growth Rate


    9 Asia Pacific Oncology Molecular Diagnostics Landscape Analysis

    • 9.1 Asia Pacific Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Oncology Molecular Diagnostics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Oncology Molecular Diagnostics Landscape Analysis by Major Countries

      • 9.3.1 China Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 9.3.2 Japan Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 9.3.4 India Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 9.3.6 South Korea Oncology Molecular Diagnostics Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Oncology Molecular Diagnostics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Oncology Molecular Diagnostics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Oncology Molecular Diagnostics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 10.3.2 Brazil Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 10.3.3 Nigeria Oncology Molecular Diagnostics Market Volume and Growth Rate

      • 10.3.4 South Africa Oncology Molecular Diagnostics Market Volume and Growth Rate 

      • 10.3.5 Argentina Oncology Molecular Diagnostics Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Exiqon

      • 11.1.1 Exiqon Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Angsana Molecular and Diagnostics

      • 11.2.1 Angsana Molecular and Diagnostics Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Beckman Coulter

      • 11.3.1 Beckman Coulter Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 EXACT Sciences

      • 11.4.1 EXACT Sciences Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Cepheid

      • 11.5.1 Cepheid Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 GeneNew

      • 11.6.1 GeneNew Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Autogenomics

      • 11.7.1 Autogenomics Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Asuragen

      • 11.8.1 Asuragen Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Agendia

      • 11.9.1 Agendia Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Becton.Dickinson and Company

      • 11.10.1 Becton.Dickinson and Company Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 BioMerieux

      • 11.11.1 BioMerieux Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Epigenomics

      • 11.12.1 Epigenomics Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Cangen Biotechnologies

      • 11.13.1 Cangen Biotechnologies Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 QIAGEN

      • 11.14.1 QIAGEN Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Eragen

      • 11.15.1 Eragen Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Diagnocure

      • 11.16.1 Diagnocure Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Roche Diagnostics

      • 11.17.1 Roche Diagnostics Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Abbott Diagnostics

      • 11.18.1 Abbott Diagnostics Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 96 Figures and 170 Tables)

    • Figure Product Picture

    • Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Molecular Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Molecular Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Molecular Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Molecular Diagnostics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Molecular Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Molecular Diagnostics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Global Oncology Molecular Diagnostics Production by Major Regions

    • Table Global Oncology Molecular Diagnostics Production Share by Major Regions

    • Figure Global Oncology Molecular Diagnostics Production Share by Major Regions in 2014

    • Figure Global Oncology Molecular Diagnostics Production Share by Major Regions in 2018

    • Figure Global Oncology Molecular Diagnostics Production Share by Major Regions in 2026

    • Table Global Oncology Molecular Diagnostics Consumption by Major Regions

    • Table Global Oncology Molecular Diagnostics Consumption Share by Major Regions

    • Figure Global Oncology Molecular Diagnostics Consumption Share by Major Regions in 2014

    • Figure Global Oncology Molecular Diagnostics Consumption Share by Major Regions in 2018

    • Figure Global Oncology Molecular Diagnostics Consumption Share by Major Regions in 2026

    • Table North America Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis

    • Table Europe Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncology Molecular Diagnostics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table North America Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure North America Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure North America Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure North America Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table North America Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table North America Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure North America Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure North America Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table North America Oncology Molecular Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table North America Oncology Molecular Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Oncology Molecular Diagnostics Consumption Share by Major Countries in 2014

    • Figure North America Oncology Molecular Diagnostics Consumption Share by Major Countries in 2018

    • Figure North America Oncology Molecular Diagnostics Consumption Share by Major Countries in 2026

    • Figure United States Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Europe Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Europe Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Europe Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Europe Oncology Molecular Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Europe Oncology Molecular Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by Major Countries in 2014

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by Major Countries in 2018

    • Figure Europe Oncology Molecular Diagnostics Consumption Share by Major Countries in 2026

    • Figure Germany Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Asia Pacific Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Asia Pacific Oncology Molecular Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Oncology Molecular Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Oncology Molecular Diagnostics Consumption Share by Major Countries in 2026

    • Figure China Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandOncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Oncology Molecular Diagnostics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Oncology Molecular Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Exiqon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exiqon

    • Figure Sales and Growth Rate Analysis of Exiqon

    • Figure Revenue and Market Share Analysis of Exiqon

    • Table Product and Service Introduction of Exiqon

    • Table Company Profile and Development Status of Angsana Molecular and Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Angsana Molecular and Diagnostics

    • Figure Sales and Growth Rate Analysis of Angsana Molecular and Diagnostics

    • Figure Revenue and Market Share Analysis of Angsana Molecular and Diagnostics

    • Table Product and Service Introduction of Angsana Molecular and Diagnostics

    • Table Company Profile and Development Status of Beckman Coulter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beckman Coulter

    • Figure Sales and Growth Rate Analysis of Beckman Coulter

    • Figure Revenue and Market Share Analysis of Beckman Coulter

    • Table Product and Service Introduction of Beckman Coulter

    • Table Company Profile and Development Status of EXACT Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EXACT Sciences

    • Figure Sales and Growth Rate Analysis of EXACT Sciences

    • Figure Revenue and Market Share Analysis of EXACT Sciences

    • Table Product and Service Introduction of EXACT Sciences

    • Table Company Profile and Development Status of Cepheid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid

    • Figure Sales and Growth Rate Analysis of Cepheid

    • Figure Revenue and Market Share Analysis of Cepheid

    • Table Product and Service Introduction of Cepheid

    • Table Company Profile and Development Status of GeneNew

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneNew

    • Figure Sales and Growth Rate Analysis of GeneNew

    • Figure Revenue and Market Share Analysis of GeneNew

    • Table Product and Service Introduction of GeneNew

    • Table Company Profile and Development Status of Autogenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autogenomics

    • Figure Sales and Growth Rate Analysis of Autogenomics

    • Figure Revenue and Market Share Analysis of Autogenomics

    • Table Product and Service Introduction of Autogenomics

    • Table Company Profile and Development Status of Asuragen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Asuragen

    • Figure Sales and Growth Rate Analysis of Asuragen

    • Figure Revenue and Market Share Analysis of Asuragen

    • Table Product and Service Introduction of Asuragen

    • Table Company Profile and Development Status of Agendia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia

    • Figure Sales and Growth Rate Analysis of Agendia

    • Figure Revenue and Market Share Analysis of Agendia

    • Table Product and Service Introduction of Agendia

    • Table Company Profile and Development Status of Becton.Dickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton.Dickinson and Company

    • Figure Sales and Growth Rate Analysis of Becton.Dickinson and Company

    • Figure Revenue and Market Share Analysis of Becton.Dickinson and Company

    • Table Product and Service Introduction of Becton.Dickinson and Company

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of Epigenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics

    • Figure Sales and Growth Rate Analysis of Epigenomics

    • Figure Revenue and Market Share Analysis of Epigenomics

    • Table Product and Service Introduction of Epigenomics

    • Table Company Profile and Development Status of Cangen Biotechnologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cangen Biotechnologies

    • Figure Sales and Growth Rate Analysis of Cangen Biotechnologies

    • Figure Revenue and Market Share Analysis of Cangen Biotechnologies

    • Table Product and Service Introduction of Cangen Biotechnologies

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of Eragen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eragen

    • Figure Sales and Growth Rate Analysis of Eragen

    • Figure Revenue and Market Share Analysis of Eragen

    • Table Product and Service Introduction of Eragen

    • Table Company Profile and Development Status of Diagnocure

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Diagnocure

    • Figure Sales and Growth Rate Analysis of Diagnocure

    • Figure Revenue and Market Share Analysis of Diagnocure

    • Table Product and Service Introduction of Diagnocure

    • Table Company Profile and Development Status of Roche Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics

    • Figure Revenue and Market Share Analysis of Roche Diagnostics

    • Table Product and Service Introduction of Roche Diagnostics

    • Table Company Profile and Development Status of Abbott Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Diagnostics

    • Figure Sales and Growth Rate Analysis of Abbott Diagnostics

    • Figure Revenue and Market Share Analysis of Abbott Diagnostics

    • Table Product and Service Introduction of Abbott Diagnostics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.